Pharmacotherapy of Bipolar Disorders
(Sprache: Englisch)
Comprehensive, concise, and up to date, this text reviews in detail all aspects of the diagnosis and pharmacological treatment of bipolar disorders, one of the most topical issues in psychiatry. The first section provides epidemiological data and...
Leider schon ausverkauft
versandkostenfrei
Buch
62.90 €
Produktdetails
Produktinformationen zu „Pharmacotherapy of Bipolar Disorders “
Comprehensive, concise, and up to date, this text reviews in detail all aspects of the diagnosis and pharmacological treatment of bipolar disorders, one of the most topical issues in psychiatry. The first section provides epidemiological data and classification of different subtypes of bipolar disorders.
Klappentext zu „Pharmacotherapy of Bipolar Disorders “
Numerous advances have been made in the pharmacotherapy of bipolar disorders in the last 5 to 10 years, to such an extent that it has become difficult for the physician to choose the most appropriate treatment according to the different parameters that must be considered. This is why it seemed necessary to us to try and give a synthetic overview of the growing amount of data to be able to respond to such questions as: Which mood stabilizer to choose and when should it be introduced ? Which therapeutic approach for a depressive episode, a manic episode or a rapid-cycling bipolar disorder?Rather than presenting treatment algorithms, the authors present a synopsis of the literature and knowledge based on daily clinical practice. At the end of each chapter, the important concepts and recommendations are summarized as key points to remember.The original French edition (published in 2004) was awarded a prize in Specialized Medicine at the 3rd International Festival of Medical Books, France. For this English edition, the text has been thoroughly revised and more than 500 new references have been added, reflecting the rapidly growing literature in the field.This book will appeal to all psychiatrists, interns and residents in psychiatry, psychologists and mental health nurses. It will also be of interest to general practitioners and any other clinicians or healthcare professionals involved in the management of patients with bipolar disorder.
Numerous advances have been made in the pharmacotherapy of bipolar disorders in the last 5 to 10 years, to such an extent that it has become difficult for the physician to choose the most appropriate treatment according to the different parameters that must be considered. This is why it seemed necessary to us to try and give a synthetic overview of the growing amount of data to be able to respond to such questions as: Which mood stabilizer to choose and when should it be introduced ? Which therapeutic approach for a depressive episode, a manic episode or a rapid-cycling bipolar disorder?
In this manual, rather than presenting treatment algorithms, we have chosen to present a synopsis of the literature and knowledge based on daily clinical practice. At the end of each chapter, the important concepts and recommendations are summarized for the reader as a reminder of the key points.
The French version of this book, (published in 2004), received a prize in the category Specialized Medicine at the 3rd international festival of the medical books, Amiens, France. Since this first French edition, the text has now been revised and more than 500 new references have been added, in order to be updated with the rapidly growing literature in the field.
In this manual, rather than presenting treatment algorithms, we have chosen to present a synopsis of the literature and knowledge based on daily clinical practice. At the end of each chapter, the important concepts and recommendations are summarized for the reader as a reminder of the key points.
The French version of this book, (published in 2004), received a prize in the category Specialized Medicine at the 3rd international festival of the medical books, Amiens, France. Since this first French edition, the text has now been revised and more than 500 new references have been added, in order to be updated with the rapidly growing literature in the field.
Inhaltsverzeichnis zu „Pharmacotherapy of Bipolar Disorders “
ForewordPreface by N. Sartorius
Chapter 1 Epidemiology of bipolar disorders
Chapter 2 Classification of bipolar disorders
Chapter 3 How to define a mood stabilizer
Chapter 4 Lithium
Chapter 5 Carbamazepine
Chapter 6 Lamotrigine
Chapter 7 Topiramate
Chapter 8 Valproic acid
Chapter 9 The role of atypical or second generation antipsychotics
Chapter 10 Other medications used for bipolar disorders
Chapter 11 Medications that may potentially induce a depressive state
Chapter 12 Medications that may potentially induce a (hypo)manic syndrome
Chapter 13 Maintenance treatment: when should be a long term treatment introduced
Chapter 14 Treatment of the depressive phases of bipolar disorders
Chapter 15 Treatment of Bipolar II disorder
Chapter 16 Treatment of manic phases
Chapter 17 Treatment of rapid cycling
Chapter 18 Treatment of mixed states
Chapter 19 Combination treatments
Chapter 20 Bipolar disorders, pregnancy and breastfeeding
Chapter 21 Bipolar disorders in children and adolescents
Chapter 22 Bipolar disorders in geriatric patients
Appendix
1. Diagnostic criteria ICM 10
2. Diagnostic criteria DSM IV
3. FDA approved medications for the treatment of bipolar disorders
4. Major guidelines for bipolar disorders
5. Trade names of selected drugs used in bipolar disorders
List of abbreviations
Index
Autoren-Porträt
Jean-Michel Aubry is a psychiatrist and psychotherapist. He is privat docent at the Medical School of the University of Geneva where he teaches Neurosciences and Psychiatry. As head of a specialised programme for bipolar disorders at the Department of Psychiatry of the Geneva University Hospital, Dr Aubry's research interests include the pharmacologicala and psychosocial treatments of bipolar disorders and more specifically, relapse prevention.François Ferrero is psychiatrist, psychotherapist, professor of psychiatry and chair of the Department of Psychiatry of the University of Geneva. His research in the domain of bipolar disorders aims to better specify the epidemiology and the links with genetics and the environment in order to develop and evaluate ever more effective therapeutic and preventive approaches.
Nicolas Schaad is the pharmacist in charge of the pharmacy la Côte that serves the hospital network of the Geneva-Lausanne region. Within this structure, he has developed a clinical pharmacy service. He is privat docent in the pharmacy section, and he also teaches in the Department of Fundamental Neurosciences at the University of Geneva. For the past few years, his research interests have been oriented towards a psychopharmacology applied to psychiatric disorders.
Mark S. Bauer is Professor in the Department of Psychiatry and Human Behavior at Brown University and on staff in the Mental Health service of the Department of Veterans Affairs Medical Center in Providence, Rhode Island, USA. He has been recognized with awards for his research, clinical expertise and teaching skills. He served for 11 years on the Scientific Advisory Board for the Depression and Bipolar Support Alliance and has been named Exemplary Psychiatrist by the National Alliance for the Mentally Ill.
Bibliographische Angaben
- 2007, 1. Auflage., 296 Seiten, Maße: 24,4 cm, Gebunden, Englisch
- By Jean-Michel Aubry, Francois Ferrero, Nicolas Schaad et al.
- Verlag: Wiley & Sons
- ISBN-10: 0470058234
- ISBN-13: 9780470058237
Sprache:
Englisch
Kommentar zu "Pharmacotherapy of Bipolar Disorders"
0 Gebrauchte Artikel zu „Pharmacotherapy of Bipolar Disorders“
Zustand | Preis | Porto | Zahlung | Verkäufer | Rating |
---|
Schreiben Sie einen Kommentar zu "Pharmacotherapy of Bipolar Disorders".
Kommentar verfassen